img

Global Hip Osteoarthritis Pain Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hip Osteoarthritis Pain Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Hip Osteoarthritis Pain Drug is to relieve pain, and cannot slow the progress of osteoarthritis.
Hip Osteoarthritis Pain Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hip Osteoarthritis Pain Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Medical Care and Personal Care are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Hip Osteoarthritis Pain Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Hip Osteoarthritis Pain Drug key manufacturers include Pfizer, Johnson and Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma and Abbott, etc. Pfizer, Johnson and Johnson, GlaxoSmithKline are top 3 players and held % sales share in total in 2022.
Hip Osteoarthritis Pain Drug can be divided into Oral, Injection and External,, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022.
Hip Osteoarthritis Pain Drug is widely used in various fields, such as Medical Care and Personal Care, etc. Medical Care provides greatest supports to the Hip Osteoarthritis Pain Drug industry development. In 2022, global % sales of Hip Osteoarthritis Pain Drug went into Medical Care filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hip Osteoarthritis Pain Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Johnson and Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Segment by Type
Oral
Injection
External

Segment by Application


Medical Care
Personal Care

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hip Osteoarthritis Pain Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hip Osteoarthritis Pain Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hip Osteoarthritis Pain Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hip Osteoarthritis Pain Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hip Osteoarthritis Pain Drug introduction, etc. Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Hip Osteoarthritis Pain Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Hip Osteoarthritis Pain Drug Market Overview
1.1 Hip Osteoarthritis Pain Drug Product Overview
1.2 Hip Osteoarthritis Pain Drug Market Segment by Type
1.2.1 Oral
1.2.2 Injection
1.2.3 External
1.3 Global Hip Osteoarthritis Pain Drug Market Size by Type
1.3.1 Global Hip Osteoarthritis Pain Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Hip Osteoarthritis Pain Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Hip Osteoarthritis Pain Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hip Osteoarthritis Pain Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Hip Osteoarthritis Pain Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Hip Osteoarthritis Pain Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Hip Osteoarthritis Pain Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Hip Osteoarthritis Pain Drug Sales Breakdown by Type (2018-2024)
2 Global Hip Osteoarthritis Pain Drug Market Competition by Company
2.1 Global Top Players by Hip Osteoarthritis Pain Drug Sales (2018-2024)
2.2 Global Top Players by Hip Osteoarthritis Pain Drug Revenue (2018-2024)
2.3 Global Top Players by Hip Osteoarthritis Pain Drug Price (2018-2024)
2.4 Global Top Manufacturers Hip Osteoarthritis Pain Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hip Osteoarthritis Pain Drug Market Competitive Situation and Trends
2.5.1 Hip Osteoarthritis Pain Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Hip Osteoarthritis Pain Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hip Osteoarthritis Pain Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Hip Osteoarthritis Pain Drug Market
2.8 Key Manufacturers Hip Osteoarthritis Pain Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hip Osteoarthritis Pain Drug Status and Outlook by Region
3.1 Global Hip Osteoarthritis Pain Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Hip Osteoarthritis Pain Drug Historic Market Size by Region
3.2.1 Global Hip Osteoarthritis Pain Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Hip Osteoarthritis Pain Drug Sales in Value by Region (2018-2024)
3.2.3 Global Hip Osteoarthritis Pain Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Hip Osteoarthritis Pain Drug Forecasted Market Size by Region
3.3.1 Global Hip Osteoarthritis Pain Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Hip Osteoarthritis Pain Drug Sales in Value by Region (2024-2034)
3.3.3 Global Hip Osteoarthritis Pain Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Hip Osteoarthritis Pain Drug by Application
4.1 Hip Osteoarthritis Pain Drug Market Segment by Application
4.1.1 Medical Care
4.1.2 Personal Care
4.2 Global Hip Osteoarthritis Pain Drug Market Size by Application
4.2.1 Global Hip Osteoarthritis Pain Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Hip Osteoarthritis Pain Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Hip Osteoarthritis Pain Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hip Osteoarthritis Pain Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Hip Osteoarthritis Pain Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Hip Osteoarthritis Pain Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Hip Osteoarthritis Pain Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Hip Osteoarthritis Pain Drug Sales Breakdown by Application (2018-2024)
5 North America Hip Osteoarthritis Pain Drug by Country
5.1 North America Hip Osteoarthritis Pain Drug Historic Market Size by Country
5.1.1 North America Hip Osteoarthritis Pain Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Hip Osteoarthritis Pain Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Hip Osteoarthritis Pain Drug Sales in Value by Country (2018-2024)
5.2 North America Hip Osteoarthritis Pain Drug Forecasted Market Size by Country
5.2.1 North America Hip Osteoarthritis Pain Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Hip Osteoarthritis Pain Drug Sales in Value by Country (2024-2034)
6 Europe Hip Osteoarthritis Pain Drug by Country
6.1 Europe Hip Osteoarthritis Pain Drug Historic Market Size by Country
6.1.1 Europe Hip Osteoarthritis Pain Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Hip Osteoarthritis Pain Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Hip Osteoarthritis Pain Drug Sales in Value by Country (2018-2024)
6.2 Europe Hip Osteoarthritis Pain Drug Forecasted Market Size by Country
6.2.1 Europe Hip Osteoarthritis Pain Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Hip Osteoarthritis Pain Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Hip Osteoarthritis Pain Drug by Region
7.1 Asia-Pacific Hip Osteoarthritis Pain Drug Historic Market Size by Region
7.1.1 Asia-Pacific Hip Osteoarthritis Pain Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Hip Osteoarthritis Pain Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Hip Osteoarthritis Pain Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Hip Osteoarthritis Pain Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Hip Osteoarthritis Pain Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Hip Osteoarthritis Pain Drug Sales in Value by Region (2024-2034)
8 Latin America Hip Osteoarthritis Pain Drug by Country
8.1 Latin America Hip Osteoarthritis Pain Drug Historic Market Size by Country
8.1.1 Latin America Hip Osteoarthritis Pain Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Hip Osteoarthritis Pain Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Hip Osteoarthritis Pain Drug Sales in Value by Country (2018-2024)
8.2 Latin America Hip Osteoarthritis Pain Drug Forecasted Market Size by Country
8.2.1 Latin America Hip Osteoarthritis Pain Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Hip Osteoarthritis Pain Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Hip Osteoarthritis Pain Drug by Country
9.1 Middle East and Africa Hip Osteoarthritis Pain Drug Historic Market Size by Country
9.1.1 Middle East and Africa Hip Osteoarthritis Pain Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Hip Osteoarthritis Pain Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Hip Osteoarthritis Pain Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Hip Osteoarthritis Pain Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Hip Osteoarthritis Pain Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Hip Osteoarthritis Pain Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Hip Osteoarthritis Pain Drug Products Offered
10.1.5 Pfizer Recent Development
10.2 Johnson and Johnson
10.2.1 Johnson and Johnson Company Information
10.2.2 Johnson and Johnson Introduction and Business Overview
10.2.3 Johnson and Johnson Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Johnson and Johnson Hip Osteoarthritis Pain Drug Products Offered
10.2.5 Johnson and Johnson Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GlaxoSmithKline Hip Osteoarthritis Pain Drug Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 Bayer
10.4.1 Bayer Company Information
10.4.2 Bayer Introduction and Business Overview
10.4.3 Bayer Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Bayer Hip Osteoarthritis Pain Drug Products Offered
10.4.5 Bayer Recent Development
10.5 Eli Lilly
10.5.1 Eli Lilly Company Information
10.5.2 Eli Lilly Introduction and Business Overview
10.5.3 Eli Lilly Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Eli Lilly Hip Osteoarthritis Pain Drug Products Offered
10.5.5 Eli Lilly Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Novartis Hip Osteoarthritis Pain Drug Products Offered
10.6.5 Novartis Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Information
10.7.2 Sanofi Introduction and Business Overview
10.7.3 Sanofi Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Sanofi Hip Osteoarthritis Pain Drug Products Offered
10.7.5 Sanofi Recent Development
10.8 Horizon Pharma
10.8.1 Horizon Pharma Company Information
10.8.2 Horizon Pharma Introduction and Business Overview
10.8.3 Horizon Pharma Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Horizon Pharma Hip Osteoarthritis Pain Drug Products Offered
10.8.5 Horizon Pharma Recent Development
10.9 Abbott
10.9.1 Abbott Company Information
10.9.2 Abbott Introduction and Business Overview
10.9.3 Abbott Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Abbott Hip Osteoarthritis Pain Drug Products Offered
10.9.5 Abbott Recent Development
10.10 Mylan
10.10.1 Mylan Company Information
10.10.2 Mylan Introduction and Business Overview
10.10.3 Mylan Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Mylan Hip Osteoarthritis Pain Drug Products Offered
10.10.5 Mylan Recent Development
10.11 Daiichi Sankyo
10.11.1 Daiichi Sankyo Company Information
10.11.2 Daiichi Sankyo Introduction and Business Overview
10.11.3 Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Daiichi Sankyo Hip Osteoarthritis Pain Drug Products Offered
10.11.5 Daiichi Sankyo Recent Development
10.12 TEVA
10.12.1 TEVA Company Information
10.12.2 TEVA Introduction and Business Overview
10.12.3 TEVA Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 TEVA Hip Osteoarthritis Pain Drug Products Offered
10.12.5 TEVA Recent Development
10.13 Almatica Pharma
10.13.1 Almatica Pharma Company Information
10.13.2 Almatica Pharma Introduction and Business Overview
10.13.3 Almatica Pharma Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Almatica Pharma Hip Osteoarthritis Pain Drug Products Offered
10.13.5 Almatica Pharma Recent Development
10.14 Astellas Pharma
10.14.1 Astellas Pharma Company Information
10.14.2 Astellas Pharma Introduction and Business Overview
10.14.3 Astellas Pharma Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Astellas Pharma Hip Osteoarthritis Pain Drug Products Offered
10.14.5 Astellas Pharma Recent Development
10.15 Tide Pharmaceutical
10.15.1 Tide Pharmaceutical Company Information
10.15.2 Tide Pharmaceutical Introduction and Business Overview
10.15.3 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Products Offered
10.15.5 Tide Pharmaceutical Recent Development
10.16 Iroko Pharmaceuticals
10.16.1 Iroko Pharmaceuticals Company Information
10.16.2 Iroko Pharmaceuticals Introduction and Business Overview
10.16.3 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Products Offered
10.16.5 Iroko Pharmaceuticals Recent Development
10.17 Hengrui Pharmaceutical
10.17.1 Hengrui Pharmaceutical Company Information
10.17.2 Hengrui Pharmaceutical Introduction and Business Overview
10.17.3 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Products Offered
10.17.5 Hengrui Pharmaceutical Recent Development
10.18 Abiogen Pharma
10.18.1 Abiogen Pharma Company Information
10.18.2 Abiogen Pharma Introduction and Business Overview
10.18.3 Abiogen Pharma Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Abiogen Pharma Hip Osteoarthritis Pain Drug Products Offered
10.18.5 Abiogen Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hip Osteoarthritis Pain Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hip Osteoarthritis Pain Drug Industrial Chain Analysis
11.4 Hip Osteoarthritis Pain Drug Market Dynamics
11.4.1 Hip Osteoarthritis Pain Drug Industry Trends
11.4.2 Hip Osteoarthritis Pain Drug Market Drivers
11.4.3 Hip Osteoarthritis Pain Drug Market Challenges
11.4.4 Hip Osteoarthritis Pain Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hip Osteoarthritis Pain Drug Distributors
12.3 Hip Osteoarthritis Pain Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Oral
Table 2. Major Company of Injection
Table 3. Major Company of External
Table 4. Global Hip Osteoarthritis Pain Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Hip Osteoarthritis Pain Drug Sales by Type (2018-2024) & (K Units)
Table 6. Global Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Hip Osteoarthritis Pain Drug Sales by Type (2018-2024) & (US& Million)
Table 8. Global Hip Osteoarthritis Pain Drug Market Share in Value by Type (2018-2024)
Table 9. Global Hip Osteoarthritis Pain Drug Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Hip Osteoarthritis Pain Drug Sales by Type (2024-2034) & (K Units)
Table 11. Global Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Hip Osteoarthritis Pain Drug Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Hip Osteoarthritis Pain Drug Sales Market Share in Value by Type (2024-2034)
Table 14. Global Hip Osteoarthritis Pain Drug Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Hip Osteoarthritis Pain Drug Sales by Type (2018-2024) & (K Units)
Table 16. North America Hip Osteoarthritis Pain Drug Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Hip Osteoarthritis Pain Drug Sales (K Units) by Type (2018-2024)
Table 18. Europe Hip Osteoarthritis Pain Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Hip Osteoarthritis Pain Drug Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Hip Osteoarthritis Pain Drug Sales (K Units) by Type (2018-2024)
Table 22. Latin America Hip Osteoarthritis Pain Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Hip Osteoarthritis Pain Drug Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Hip Osteoarthritis Pain Drug Sales by Company (2018-2024) & (K Units)
Table 26. Global Hip Osteoarthritis Pain Drug Sales Share by Company (2018-2024)
Table 27. Global Hip Osteoarthritis Pain Drug Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Hip Osteoarthritis Pain Drug Revenue Share by Company (2018-2024)
Table 29. Global Market Hip Osteoarthritis Pain Drug Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Hip Osteoarthritis Pain Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Hip Osteoarthritis Pain Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hip Osteoarthritis Pain Drug as of 2022)
Table 33. Date of Key Manufacturers Enter into Hip Osteoarthritis Pain Drug Market
Table 34. Key Manufacturers Hip Osteoarthritis Pain Drug Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Hip Osteoarthritis Pain Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Hip Osteoarthritis Pain Drug Sales by Region (2018-2024) & (K Units)
Table 38. Global Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Hip Osteoarthritis Pain Drug Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Hip Osteoarthritis Pain Drug Sales Market Share in Value by Region (2018-2024)
Table 41. Global Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Hip Osteoarthritis Pain Drug Sales by Region (2024-2034) & (K Units)
Table 43. Global Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Hip Osteoarthritis Pain Drug Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Hip Osteoarthritis Pain Drug Sales Market Share in Value by Region (2024-2034)
Table 46. Global Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Hip Osteoarthritis Pain Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Hip Osteoarthritis Pain Drug Sales by Application (2018-2024) & (K Units)
Table 49. Global Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Hip Osteoarthritis Pain Drug Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Hip Osteoarthritis Pain Drug Sales Market Share in Value by Application (2018-2024)
Table 52. Global Hip Osteoarthritis Pain Drug Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Hip Osteoarthritis Pain Drug Sales by Application (2024-2034) & (K Units)
Table 54. Global Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Hip Osteoarthritis Pain Drug Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Hip Osteoarthritis Pain Drug Sales Market Share in Value by Application (2024-2034)
Table 57. Global Hip Osteoarthritis Pain Drug Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Hip Osteoarthritis Pain Drug Sales by Application (2018-2024) (K Units)
Table 59. North America Hip Osteoarthritis Pain Drug Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Hip Osteoarthritis Pain Drug Sales by Application (2018-2024) (K Units)
Table 61. Europe Hip Osteoarthritis Pain Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Hip Osteoarthritis Pain Drug Sales by Application (2018-2024) (K Units)
Table 65. Latin America Hip Osteoarthritis Pain Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Hip Osteoarthritis Pain Drug Sales by Country (2018-2024) & (K Units)
Table 69. North America Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Hip Osteoarthritis Pain Drug Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Hip Osteoarthritis Pain Drug Sales Market Share in Value by Country (2018-2024)
Table 72. North America Hip Osteoarthritis Pain Drug Sales by Country (2024-2034) & (K Units)
Table 73. North America Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Hip Osteoarthritis Pain Drug Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Hip Osteoarthritis Pain Drug Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Hip Osteoarthritis Pain Drug Sales by Country (2018-2024) & (K Units)
Table 77. Europe Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Hip Osteoarthritis Pain Drug Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Hip Osteoarthritis Pain Drug Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Hip Osteoarthritis Pain Drug Sales by Country (2024-2034) & (K Units)
Table 81. Europe Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Hip Osteoarthritis Pain Drug Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Hip Osteoarthritis Pain Drug Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Hip Osteoarthritis Pain Drug Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Hip Osteoarthritis Pain Drug Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Hip Osteoarthritis Pain Drug Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Hip Osteoarthritis Pain Drug Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Hip Osteoarthritis Pain Drug Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Hip Osteoarthritis Pain Drug Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share in Value by Country (2024-2034)
Table 108. Pfizer Company Information
Table 109. Pfizer Introduction and Business Overview
Table 110. Pfizer Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Pfizer Hip Osteoarthritis Pain Drug Product
Table 112. Pfizer Recent Development
Table 113. Johnson and Johnson Company Information
Table 114. Johnson and Johnson Introduction and Business Overview
Table 115. Johnson and Johnson Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Johnson and Johnson Hip Osteoarthritis Pain Drug Product
Table 117. Johnson and Johnson Recent Development
Table 118. GlaxoSmithKline Company Information
Table 119. GlaxoSmithKline Introduction and Business Overview
Table 120. GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. GlaxoSmithKline Hip Osteoarthritis Pain Drug Product
Table 122. GlaxoSmithKline Recent Development
Table 123. Bayer Company Information
Table 124. Bayer Introduction and Business Overview
Table 125. Bayer Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Bayer Hip Osteoarthritis Pain Drug Product
Table 127. Bayer Recent Development
Table 128. Eli Lilly Company Information
Table 129. Eli Lilly Introduction and Business Overview
Table 130. Eli Lilly Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Eli Lilly Hip Osteoarthritis Pain Drug Product
Table 132. Eli Lilly Recent Development
Table 133. Novartis Company Information
Table 134. Novartis Introduction and Business Overview
Table 135. Novartis Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Novartis Hip Osteoarthritis Pain Drug Product
Table 137. Novartis Recent Development
Table 138. Sanofi Company Information
Table 139. Sanofi Introduction and Business Overview
Table 140. Sanofi Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Sanofi Hip Osteoarthritis Pain Drug Product
Table 142. Sanofi Recent Development
Table 143. Horizon Pharma Company Information
Table 144. Horizon Pharma Introduction and Business Overview
Table 145. Horizon Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Horizon Pharma Hip Osteoarthritis Pain Drug Product
Table 147. Horizon Pharma Recent Development
Table 148. Abbott Company Information
Table 149. Abbott Introduction and Business Overview
Table 150. Abbott Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Abbott Hip Osteoarthritis Pain Drug Product
Table 152. Abbott Recent Development
Table 153. Mylan Company Information
Table 154. Mylan Introduction and Business Overview
Table 155. Mylan Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Mylan Hip Osteoarthritis Pain Drug Product
Table 157. Mylan Recent Development
Table 158. Daiichi Sankyo Company Information
Table 159. Daiichi Sankyo Introduction and Business Overview
Table 160. Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Daiichi Sankyo Hip Osteoarthritis Pain Drug Product
Table 162. Daiichi Sankyo Recent Development
Table 163. TEVA Company Information
Table 164. TEVA Introduction and Business Overview
Table 165. TEVA Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. TEVA Hip Osteoarthritis Pain Drug Product
Table 167. TEVA Recent Development
Table 168. Almatica Pharma Company Information
Table 169. Almatica Pharma Introduction and Business Overview
Table 170. Almatica Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Almatica Pharma Hip Osteoarthritis Pain Drug Product
Table 172. Almatica Pharma Recent Development
Table 173. Astellas Pharma Company Information
Table 174. Astellas Pharma Introduction and Business Overview
Table 175. Astellas Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. Astellas Pharma Hip Osteoarthritis Pain Drug Product
Table 177. Astellas Pharma Recent Development
Table 178. Tide Pharmaceutical Company Information
Table 179. Tide Pharmaceutical Introduction and Business Overview
Table 180. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 181. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Product
Table 182. Tide Pharmaceutical Recent Development
Table 183. Iroko Pharmaceuticals Company Information
Table 184. Iroko Pharmaceuticals Introduction and Business Overview
Table 185. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 186. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Product
Table 187. Iroko Pharmaceuticals Recent Development
Table 188. Hengrui Pharmaceutical Company Information
Table 189. Hengrui Pharmaceutical Introduction and Business Overview
Table 190. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 191. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Product
Table 192. Hengrui Pharmaceutical Recent Development
Table 193. Abiogen Pharma Company Information
Table 194. Abiogen Pharma Introduction and Business Overview
Table 195. Abiogen Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 196. Abiogen Pharma Hip Osteoarthritis Pain Drug Product
Table 197. Abiogen Pharma Recent Development
Table 198. Key Raw Materials Lists
Table 199. Raw Materials Key Suppliers Lists
Table 200. Hip Osteoarthritis Pain Drug Market Trends
Table 201. Hip Osteoarthritis Pain Drug Market Drivers
Table 202. Hip Osteoarthritis Pain Drug Market Challenges
Table 203. Hip Osteoarthritis Pain Drug Market Restraints
Table 204. Hip Osteoarthritis Pain Drug Distributors List
Table 205. Hip Osteoarthritis Pain Drug Downstream Customers
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of Figures
Figure 1. Hip Osteoarthritis Pain Drug Product Picture
Figure 2. Global Hip Osteoarthritis Pain Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Hip Osteoarthritis Pain Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Hip Osteoarthritis Pain Drug Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Oral
Figure 6. Global Oral Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Injection
Figure 8. Global Injection Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of External
Figure 10. Global External Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Hip Osteoarthritis Pain Drug Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Hip Osteoarthritis Pain Drug Sales Market Share by Type in 2022 & 2034
Figure 13. North America Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Type in 2022
Figure 14. North America Hip Osteoarthritis Pain Drug Sales Market Share in Value by Type in 2022
Figure 15. Europe Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Type in 2022
Figure 16. Europe Hip Osteoarthritis Pain Drug Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share in Value by Type in 2022
Figure 19. Latin America Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Hip Osteoarthritis Pain Drug Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Hip Osteoarthritis Pain Drug Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Hip Osteoarthritis Pain Drug Revenue in 2022
Figure 25. Hip Osteoarthritis Pain Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Medical Care
Figure 27. Global Medical Care Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Personal Care
Figure 29. Global Personal Care Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Global Hip Osteoarthritis Pain Drug Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Hip Osteoarthritis Pain Drug Sales Market Share by Application in 2022 & 2034
Figure 32. North America Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Application in 2022
Figure 33. North America Hip Osteoarthritis Pain Drug Sales Market Share in Value by Application in 2022
Figure 34. Europe Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Application in 2022
Figure 35. Europe Hip Osteoarthritis Pain Drug Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share in Value by Application in 2022
Figure 38. Latin America Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Hip Osteoarthritis Pain Drug Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Hip Osteoarthritis Pain Drug Manufacturing Cost Structure
Figure 43. Hip Osteoarthritis Pain Drug Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries